The sales are already going down
Citing the loss of patent protection, drug maker Merck reported that third-quarter 2013 sales of its male pattern hair loss drug Propecia declined 32 percent from the same period in 2012 to $71 million.
http://www.reichandbinstock.com/homepage/blog/391-propecia-victims-down-but-not-out.html
But that doesn’t stop the FDA and the manufactures from approving 1mg generic
Manufacturer: ACCORD HLTHCARE INC
Approval date: November 5, 2013
Strength(s): 1MG [AB]
Manufacturer: ACTAVIS TOTOWA
Approval date: November 5, 2013
Strength(s): 1MG [AB]
Manufacturer: AUROBINDO PHARMA LTD
Approval date: November 5, 2013
Strength(s): 1MG [AB]
Manufacturer: DR REDDYS LABS INC
Approval date: July 28, 2006
Strength(s): 1MG [AB]
Manufacturer: HETERO LABS LTD III
Approval date: July 1, 2013
Strength(s): 1MG [AB]
Manufacturer: MYLAN PHARMS INC
Approval date: November 5, 2013
Strength(s): 1MG [AB]
Manufacturer: SUN PHARMA GLOBAL
Approval date: July 1, 2013
Strength(s): 1MG [AB]
Manufacturer: TEVA
Approval date: November 5, 2013
Strength(s): 1MG [AB]
http://www.drugs.com/availability/generic-propecia.html
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&#totable
Under the current law you can’t sue the generic manufacturer, when will it end!